Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection

Journal of Clinical Investigation(2021)10.1172/jci149125Source: DataRank Database

Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 176 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access176 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (17)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Elsa Du Bruyn ORCID,Cari Stek ORCID,Remy Daroowala,René Goliath ORCID,Fatima Abrahams

Live enrichment

PubMed:23304386

Office of Extramural Research, National Institutes of Health

Grant: R21AI148027

European and Developing Countries Clinical Trials Partnership

Grant: TMA2017SF-1951-TB-SPEC

Wellcome

Grant: 104803,203135,222574

Wellcome Trust

Grant: 222574

National COVID Testing Africa AAPs/Centre

Wellcome Trust

Grant: 203135

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)

Wellcome Trust

Grant: 104803

Host directed therapies against tuberculosis.

National Institutes of Health

Grant: 1R21AI148027-01

Contribution of the CD153/CD30 axis to Mycobacterium tuberculosis control in humans

hybridLicense: cc-by

publisherhttp://www.jci.org/articles/view/149125/files/pdf

publisherhttps://www.jci.org/articles/view/149125/files/pdf

repositoryhttps://figshare.com/articles/journal_contribution/Relationship_of_SARS-CoV-2-specific_CD4_response_to_COVID-19_severity_and_impact_of_HIV-1_and_tuberculosis_coinfection_/14790612

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8203446

https://doi.org/10.1172/jci149125

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

AdultCD4-Positive T-LymphocytesMaleCoinfectionSARS-CoV-2COVID-19Mycobacterium tuberculosisMiddle AgedSeverity of Illness IndexHIV-1HumansTuberculosisFemaleResearch ArticleAged

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261590.v1figshare

Additional file 1 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261590figshare

Additional file 2 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261593.v1figshare

Additional file 2 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261593figshare

Additional file 3 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261596.v1figshare

Additional file 3 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261596figshare

Additional file 4 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261599.v1figshare

Additional file 4 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261599figshare

Additional file 5 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261602.v1figshare

Additional file 5 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261602figshare

Additional file 6 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261605.v1figshare

Additional file 6 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261605figshare

Additional file 7 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261608.v1figshare

Additional file 7 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261608figshare

Additional file 8 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261611.v1figshare

Additional file 8 of Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

10.6084/m9.figshare.21261611figshare